Evidence map›Paper›PMID 32623394›Full record

ArticleJournal of Alzheimer's disease : JAD2020

Association of Peripheral Insulin Resistance and Other Markers of Type 2 Diabetes Mellitus with Brain Amyloid Deposition in Healthy Individuals at Risk of Dementia.

Timo Pekkala, Anette Hall, Francesca Mangialasche, Nina Kemppainen, Patrizia Mecocci, Tiia Ngandu, Juha O Rinne, Hilkka Soininen, Jaakko Tuomilehto, Miia Kivipelto and 1 more

Open access · bronzeAbstract readLetter
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Diabetes and dementia: Clinical perspective, innovation, knowledge gaps.Journal of diabetes and its complications · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 5 countries.

Timo PekkalaInstitute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland.
Anette HallInstitute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland.
Francesca MangialascheDivision of Clinical Geriatrics, Center for Alzheimer Research, NVS, Karolinska Institutet, Stockholm, Sweden.
Nina KemppainenTurku PET Centre, University of Turku, Turku, Finland.
Patrizia MecocciDepartment of Medicine, Institute of Gerontology and Geriatrics, University of Perugia, Perugia, Italy.
Tiia NganduDivision of Clinical Geriatrics, Center for Alzheimer Research, NVS, Karolinska Institutet, Stockholm, Sweden.
Juha O RinneTurku PET Centre, University of Turku, Turku, Finland.
Hilkka SoininenInstitute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland.
Jaakko TuomilehtoPublic Health Promotion Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Miia KivipeltoInstitute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland.
Alina SolomonInstitute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland.
University of Eastern Finland · FIUniversity of Turku · FIKarolinska Institutet · SEStockholm University · SEUniversity of Helsinki · FIUniversity of Perugia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We explored the association of type 2 diabetes related blood markers with brain amyloid accumulation on PiB-PET scans in 41 participants from the FINGER PET sub-study. We built logistic regression models for brain amyloid status with12 plasma markers of glucose and lipid metabolism, controlled for diabetes and APOEɛ4 carrier status. Lower levels of insulin, insulin resistance index (HOMA-IR), C-peptide, and plasminogen activator (PAI-1) were associated with amyloid positive status, although the results were not significant after adjusting for multiple testing. None of the models found evidence for associations between amyloid status and fasting glucose or HbA1c.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseAmyloidApolipoprotein E4BiomarkersBrainDiabetes Mellitus, Type 2FemaleHumansInsulinInsulin ResistanceMaleMiddle AgedRiskAmyloidApolipoprotein E4BiomarkersInsulinAmyloid-βapolipoprotein Eplasminogen activatorpositron emission tomographytype 2 diabetes

Identifiers

PMID32623394
PMCPMC7504982
OpenAlexW3039386138

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.